Midterm evaluation of the Tissuemed (Aspire) porcine bioprosthesis: 493 patients, 506 bioprostheses Ira R.A Goldsmith, MD, Tomasz J Spyt, Maria Boehm, Simon Kendall, Michael D Rosin The Annals of Thoracic Surgery Volume 71, Issue 5, Pages 1471-1476 (May 2001) DOI: 10.1016/S0003-4975(01)02397-9 Copyright © 2001 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 New York Heart Association functional class before operation (Pre-Op) and at follow-up. The Annals of Thoracic Surgery 2001 71, 1471-1476DOI: (10.1016/S0003-4975(01)02397-9) Copyright © 2001 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Influence of age at operation on patients’ survival at 8 years. The Annals of Thoracic Surgery 2001 71, 1471-1476DOI: (10.1016/S0003-4975(01)02397-9) Copyright © 2001 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Valve position and patients’ survival at 8 years. (AVR = aortic valve replacement; DVR = double valve replacement; MVR = mitral valve replacement.) The Annals of Thoracic Surgery 2001 71, 1471-1476DOI: (10.1016/S0003-4975(01)02397-9) Copyright © 2001 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Aortic valve replacement: influence of implant size on patients’ survival at 8 years. The Annals of Thoracic Surgery 2001 71, 1471-1476DOI: (10.1016/S0003-4975(01)02397-9) Copyright © 2001 The Society of Thoracic Surgeons Terms and Conditions
Fig 5 Aortic valve diagnosis and patients’ survival at 8 years. (AR = aortic regurgitation; AS = aortic stenosis.) The Annals of Thoracic Surgery 2001 71, 1471-1476DOI: (10.1016/S0003-4975(01)02397-9) Copyright © 2001 The Society of Thoracic Surgeons Terms and Conditions